The goals of the program are to:

• Build solid working collaboration between USA, Germany and other G20 nations on translational clinical neuroscience including all aspects of the Brain Mapping and Therapeutics.

• Build strategic industry-academia-government alliance for brain discovery, diseases prevention, diagnosis and treatment

• Facilitate rapid integration translation and commercialization of innovations in this field of Brain Mapping & Therapeutics world wide

• Launch complementary Brain Mapping initiatives across the G20 nations

• Facilitate Clinical trial and formulation of joint Institutional Review Board taskforce across G20